Please check your internet connection and try again.
# Arsil-DX
## Overview
Arsil-DX is a proprietary fixed-dose combination commonly marketed in regions such as South Asia. It typically contains **Dextromethorphan Hydrobromide** (antitussive) and **Chlorpheniramine Maleate** (first-generation antihistamine). Other regions may occasionally include phenylephrine; verify the specific product label for regional variations.
## Primary Indications
Symptomatic relief of cough due to minor throat and bronchial irritation (common cold, allergic rhinitis, or upper respiratory track infections).
## Adult Dosing
* **Standard dose:** 10 mL syrup (typically containing 10–15 mg Dextromethorphan / 2 mg Chlorpheniramine) every 6–8 hours as needed.
* **Maximum:** Do not exceed 40 mL per 24 hours.
## Pediatric Dosing
* **6–12 years:** 5 mL every 6–8 hours as needed. Maximum 20 mL/24 hours.
* **Under 6 years:** Not recommended without direct physician supervision due to risks of respiratory depression and paradoxical excitation.
* **Note:** Dosing varies significantly by local product concentration; always consult the specific bottle label for active ingredient concentrations.
## Dose Adjustments
* **Hepatic/Renal Impairment:** Use with caution. Dose reduction or increased interval may be required due to the metabolism and elimination profiles of the individual components.
* **Elderly:** Increased sensitivity to the anticholinergic effects of chlorpheniramine (sedation, urinary retention, confusion). Use lowest effective dose.
## Contraindications
* Hypersensitivity to any component.
* Concurrent use with or within 14 days of Monoamine Oxidase Inhibitors (MAOIs).
* Presence of severe respiratory insufficiency or asthma attack.
* Narrow-angle glaucoma, symptomatic prostatic hypertrophy, or bladder neck obstruction.
## Adverse Effects
* **Drowsiness/Sedation:** Common due to chlorpheniramine.
* **Anticholinergic effects:** Dry mouth, blurred vision, constipation, and urinary retention.
* **CNS:** Dizziness, headache, or paradoxical excitation (more common in children).
* **GI:** Nausea or abdominal pain.
## Key Drug Interactions
* **MAOIs:** Risk of serotonin syndrome and hypertensive crisis.
* **CNS Depressants:** Alcohol, opioids, or benzodiazepines will synergistically increase sedation and respiratory depression.
* **SSRI/SNRIs:** Increased risk of serotonin syndrome with dextromethorphan.
## Monitoring
* Monitor for excessive sedation or respiratory depression.
* Assess for relief of cough symptoms.
* Monitor blood pressure/heart rate if phenylephrine is also included in your specific formulation.
## Clinical Pearls
* **Sedation Warning:** Warn patients about driving or operating machinery due to the sedative nature of chlorpheniramine.
* **Overdose Risk:** Dextromethorphan has potential for misuse; avoid use in patients with a history of substance abuse.
* **Ineffectiveness:** Professional guidelines (e.g., ACCP) often note that over-the-counter cough suppressants have limited efficacy in acute cough. Do not use for chronic cough (e.g., asthma, COPD, or smoking-related cough).
***
**Disclaimer:** This information is clinical support and does not replace current product labeling or standard institutional protocols. Dosing may vary based on local manufacturing and specific concentrations. Always verify the current prescribing information and the patient's individual profile before administration.
